Life Sciences Newsbrief — October 2009, Issue #12

Pharma and life sciences tax news: Vol. 8, No. 9, September 29, 2009

Medical device industry not alone in opposing Baucus health reform bill's $4 billion annual fee on the sector

Senate Finance Committee Chairman Max Baucus's healthcare reform bill, "America's Healthy Future Act," has invoked strong opposition from Democrats and Republicans even though he spent months working with both parties to draft the bill, hoping it would find broader support than the House's reform proposal.

360° Insight: The business implications of health reform regardless of how the political winds blow

In this upcoming webcast series, PricewaterhouseCoopers will address significant issues that all business stakeholders should be thinking about regardless of the final shape of policy decisions coming out of Washington, D.C. Whatever the final outcome, PricewaterhouseCoopers will brief you on what to expect and how this will impact your organization.

Reversing course?

Life Sciences venture capital investments rise in second quarter, sector captures highest share in MoneyTree™history

With venture capital investments in the tech sector down for the first six months of 2009, the life sciences industry offered one of the few bright spots during tough economic times. "Reversing Course?", a new report from PricewaterhouseCoopers, looks at how the Life Sciences sector is performing and the factors influencing its success.